A prospective study assessing hs-cTn in 1599 patients with COPD over a period of 18 months showed that those with the highest concentrations of hs-cTnI were at greater risk of CV events and death after adjustment for confounding factors [30]. The gene discussed is TNNI3; the disease is chronic obstructive pulmonary disease.